Naveen Pemmaraju: Omacetaxine + VEN in Patients with R/R MDS/AML with RUNX1 Mutation

Naveen Pemmaraju, BPDCN

Jonathan Friedberg: PROs vs Clinician-reported Adverse Events in a Large Clinical Trial

Friedberg Jonathan

Elizabeth Whittington: Grateful to Witness St. Jude’s Global Mission at the United Nations

Elizabeth Whittington

Tedros Adhanom Ghebreyesus: Thanks to World Leaders for Showing Strong Support for UNGA Political Declaration

UNGA

100 Influential People in Oncology 2025 - Nominations are Open!

100 Influential People in Oncology 2025

Oncology News, Insights, Stories by OncoDaily

OncoCalendar

The ESO Refresher Course on Breast Cancer

European School of Oncology

21 Nov
ESO

CCI4EU 3rd Capacity Building Conference on Effective Patient Pathways

European School of Oncology

15 Oct
CCI4EU Conference

10th ESO SIOPE Masterclass in Paediatric Oncology

European School of Oncology

01 Oct
ESO SIOPE

50th International Congress "October Health Days"

European School of Oncology

23 Oct
Health Days

Hack4Hope 2025: 2nd Edition

Paris-Saclay Cancer Cluster (PSCC)

03 Dec
Hack4Hope 2025

OncoDaily Magazine